Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0038 USD | +43.40% |
|
+31.03% | +322.22% |
Business Summary
Number of employees: 2
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/13/22 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/13/22 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 15/14/15 |
David Dickason
PRN | Corporate Officer/Principal | - | 15/20/15 |
Marc M. Radin
AUD | Comptroller/Controller/Auditor | - | 01/13/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/13/22 |
Director/Board Member | - | 22/23/22 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/13/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 365,418,647 | 341,184,734 ( 93.37 %) | 0 | 93.37 % |
Stock B | 0 | 37,500 | 0 | 0 |
Company contact information
RespireRx Pharmaceuticals, Inc.
126 Valley Road Suite C
07452, Glen Rock
+201 444 4947
http://www.respirerx.com![address RespireRx Pharmaceuticals Inc.(RSPI)](https://cdn.zonebourse.com/static/address/111313448.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+322.22% | 30.58L | |
+16.49% | 12TCr | |
+21.73% | 12TCr | |
+22.65% | 2.66TCr | |
-21.81% | 1.99TCr | |
-16.87% | 1.63TCr | |
-18.81% | 1.55TCr | |
-44.74% | 1.55TCr | |
+62.72% | 1.48TCr | |
+3.09% | 1.37TCr |
- Stock Market
- Equities
- RSPI Stock
- Company RespireRx Pharmaceuticals Inc.